SPAC Terms: Where Do All the IPOs Stand? (A Summary of Changes)
by Kristi Marvin on 2020-04-30 at 10:53am

SPAC TERMS

Since many of the IPOs we’re now seeing come to market were initially filed “pre-Covid” and the teams have had to adjust their terms “post-Covid”, I thought it would be helpful to provide a summary of the changes (so far) in an effort to better track the trends.

As you can see below, of the recently priced SPACs, all of the teams have had prior SPAC experience.  Plus, four of the five initially started with 1/4 warrant structures and all now reflect 1/3 warrant structures.  The fact that only elite SPACs have priced to-date makes sense since these teams would be the first to attempt an IPO given their successful prior history and brand-name status. I.e., you don’t send in your weakest player when the game is on the line.  However, you’ll notice that every single IPO that has priced to-date has had to adjust one or more of their main terms (note:  if a term has been changed, it has been highlighted in blue).

deal-terms-3

We have ten more SPACs on deck to IPO and while many of them have yet to file new S-1 amendments, of the ones that have, some have already made adjustments in anticipation of pricing in the next two weeks.  In particular, GigCapital3 and Roth CH, which re-filed last night.  Additionally, B. Riley II and Jaws Acquisition Corp., which filed as recently as last Thursday and Tuesday, respectively, have already taken into consideration the current climate and their initial filings reflect current market terms.  So no changes are expected with those two.

Collective Growth is widely expected to price tonight, but it is unlikely any additional changes will be made on their SPAC either. However, it will be interesting to see if the rest of the filed deals make further adjustments in order to make their IPOs more sell-able.

In the meantime, any new SPACs yet-to-be-filed will probably reflect these changes for at least through May.  After that, hard to say and a lot depends on what the world looks like heading into June.  But for now:

  • Brand-name teams are looking at 24 months and 1/3 warrants.
  • Sub-brand name and/or new teams without SPAC experience yet are looking at 18-24 months with 1/2 warrants.
  • The tier below that, 3/4’s to 1 full warrant with 18 months.
  • The small, Asia-focused deals, 12 months plus multiple 3-month extensions and full warrants and maybe rights and most likely, many of these will need to start over-funding trusts as well.

But keep in mind, the above is not necessarily what every investors wants, but what the bankers will try to go out with (some will push the envelope too). Also keep in mind that the SPAC pendulum of terms can change on a dime.  What could potentially swing terms the other way (in favor of teams) is if we have a number of successful combination announcements and closings.  Remains to be seen if that can happen during Covid, but successful deals have provided significant momentum for the whole category in the past.  Let’s see what happens.

 

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved